Previous 10 | Next 10 |
home / stock / podd / podd articles
The markets exhibited a mixed trend Monday, with technology heavyweights experienced a slight downturn as investors adopt a cautious approach ahead...
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. In "Buy Chevron Stock. ...
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s sessio...
Insulet Corporation (NASDAQ: PODD) shares traded lower Thursday. The stock has been under pressure this year amid the popularity of weight loss dru...
Benzinga AI Powerhouse: Palantir And PwC Team Up To Accelerate Data-Driven Operations Palantir Technologies Inc (NYSE: PLTR) is expanding its...
Medical device company Insulet Corp (NASDAQ: PODD) disclosed that Wayde McMillan has decided to resign as Executive Vice President, ...
Editor’s note: This story has been updated to reflect the release times for economic data Monday in U.S. eastern time. The U.S. stock market ...
JP Morgan raised the price target for The Progressive Corporation (NYSE: PGR) from $146 to $149. JP Morgan analyst Jimmy Bhullar maintained an O...
In the middle of the AI revolution and the Federal Reserve's steadfast stance on interest rates, the stock market has seen unexpected twists an...
News, Short Squeeze, Breakout and More Instantly...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the second quarter of 2024 on August 8, 2024 after the close of the financial...
Largest, longest, and most racially diverse study of automated insulin delivery (AID) conducted in people with type 2 diabetes to date Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® bra...
Following a successful limited market release, the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) is now fully available with Dexcom G6 and Abbott FreeStyle Libre 2 Plus in these countries Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tub...